R&D Making a difference for traumatic brain injury patients TBI is the leading cause of death and disability in young adults in the developed world.
R&D The transformation of brain implants Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, tells us how Neurosoft's electrode implant aims to reduce inflammation and scar tissue for patients, provide higher quality brain recor
News FDA fast-tracks NeuroVive's traumatic brain injury drug The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma NeuroVive, hastening its development and review.
News Vasopharm drug could limit damage caused by brain injuries German biotech moves into phase 3 after a long wait
News Novavax critic Shah Capital ends its activism campaign Shah Capital has ended attempts to exert influence over vaccine firm Novavax, bringing more than years of pressure on management to an end.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
